Matthew D. Smith, P. Calabresi, P. Bhargava
Feb 1, 2018
Citations
1
Influential Citations
36
Citations
Quality indicators
Journal
European Journal of Immunology
Abstract
Dimethyl fumarate (DMF) treatment in multiple sclerosis (MS) increased the proportion of immunoregulatory CD56bright NK cells and this change was proportional to reductions in CD8+ memory T cells. DMF and monomethyl fumarate (MMF) treatment in vitro had directs effects on NK cells and promoted degranulation and cytotoxicity.